Depo-Testosterone (Testosterone)

Quick links to important sections

Depo-Testosterone (Testosterone)

Treatment option: Hypogonadism

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Depo-Testosterone (Testosterone)

Quick Facts: Depo-Testosterone

Property Description
Active Ingredient Testosterone cypionate (an ester)
Form Injectable solution (oil-based)
Pharmacological Class Androgens (Sex hormones)
Common Use Hormone replacement for deficiency
Origin Synthetic derivative (of natural testosterone)

What Type of Medicine is Depo-Testosterone (Testosterone)?

Depo-Testosterone is the trade name for the injectable solution whose active compound is testosterone cypionate. It belongs to the Androgens pharmacological class, which are essential naturally occurring sex hormones. This medication is functionally defined as a Hormone Replacement Therapy (HRT) agent, used to supplement the body’s supply of this vital hormone. The formulation is clinically recognized for its efficacy in restoring serum testosterone levels in men with hormonal deficiencies.

The active ingredient, testosterone cypionate, is a synthetic derivative of the natural testosterone molecule. This compound is used primarily for adult males with confirmed androgen deficiency, a typical use scenario for this specific HRT agent. Due to its potent nature, the medication is categorized strictly as a prescription-only medicine.


The Form and Composition of Testosterone Cypionate

Testosterone cypionate is formulated as a unique, long-acting injectable solution for deep intramuscular injection. The preparation is a single-active ingredient solution where the testosterone cypionate is dissolved in an oil-based vehicle, typically cottonseed oil.

The key differentiating feature of this compound is the presence of the cypionate ester. This chemical modification makes the hormone highly lipophilic, a mechanism that ensures the medication is released very slowly from the injection site. This design provides a controlled, long-acting profile, which helps sustain consistent hormone levels over an extended period.


What is the General Purpose of this Androgen Replacement?

The primary general purpose of this medication is to provide primary endogenous androgen replacement when an individual has a medically confirmed deficiency. By restoring the concentration of testosterone to a normal range, the medication helps support the maintenance of essential physiological functions.

This includes supporting key areas such as muscle integrity, bone density, and overall energy regulation, outcomes that are consistently validated through endocrinology research. The sustained hormonal action of the injection achieves this therapeutic outcome, serving as a reliable substitute for deficient hormone production.

What side effects are possible with Depo-Testosterone (Testosterone)?

Possible Side Effects and Safety Information

The regulatory safety profile for testosterone cypionate (Depo-Testosterone) categorizes potential adverse reactions by frequency and the body system affected. These classifications structure the understanding of the medicine’s risks, strictly based on official regulatory data.


Frequency-Classified Adverse Reactions

Classification Examples of Documented Effects
Common Increase in red blood cell count (polycythemia), increase in hematocrit, weight gain, acne, gynecomastia, prostatic hypertrophy (BPH), and hypertension.
Uncommon Changes in libido, depression, anxiety, nausea, and localized injection site reactions.
Rare Priapism (persistent, painful erection) and cholestatic jaundice (a liver condition).
Frequency Not Known Male pattern baldness, hirsutism (excessive hair growth), and sleep apnea.

Serious Adverse Reactions and Safety Constraints

The official label identifies conditions considered serious risks or absolute contraindications. The drug is strictly contraindicated in males with known or suspected prostatic or breast carcinoma. Severe cardiac, renal, or hepatic disease also represents an absolute restriction due to the risk of fluid retention.

Serious risks explicitly documented include the development or exacerbation of prostatic carcinoma, thromboembolic events (like Deep Vein Thrombosis or Pulmonary Embolism) associated with severe polycythemia, and rare hepatocellular neoplasms (liver tumors).

Population-Specific Notes state that older adults have an increased risk of developing prostatic disorders. Furthermore, mandatory laboratory monitoring of hematocrit, hemoglobin, PSA, and liver function tests is required during long-term therapy to manage these documented risks.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

The regulatory profile for Depo-Testosterone overdose is based on the consequences of excessive androgen exposure and high-dose abuse, as there is no specific antidote known. Documented clinical manifestations of overexposure requiring action include priapism (a painful, prolonged erection) and excessive sexual stimulation. Other signs of excess androgen effect, such as gynecomastia or acne, may also occur.

High-dose abuse is associated with severe, potentially life-threatening outcomes. These include major adverse cardiovascular events such as myocardial infarction (heart attack), stroke, and Venous Thromboembolism (VTE). Prolonged overexposure is also documented in connection with hepatotoxicity and the development of hepatic neoplasms.

Emergency Response and Required Actions

The regulatory guidance mandates immediate discontinuation of the injection if severe events are suspected, including VTE, suspected heart failure-related edema, or priapism. Urgent medical attention must be sought immediately for any life-threatening event.

Management consists of providing symptomatic and supportive treatment. Additionally, periodic monitoring of hematocrit levels is required. Regulatory rules mandate permanent cessation of the medicine if hematocrit elevation reoccurs. In pediatric patients, excess exposure is linked to acceleration of bone age and premature closure of epiphyses.

Therapeutic Uses of Depo-Testosterone (Testosterone)

What Depo-Testosterone (Testosterone) Treats: Main Uses and Benefits

Depo-Testosterone (testosterone cypionate) is an injectable form of supportive therapy, primarily used for managing conditions associated with a deficiency or absence of the body's natural testosterone. This supportive approach is applied across domains where additional symptomatic support is needed.

This medication is considered relevant for males presenting with specific conditions characterized by periods of heightened symptoms of hypogonadism, specifically primary hypogonadism and hypogonadotropic hypogonadism. These are conditions where functional stability becomes affected due to inadequate hormone levels.

When applied when appropriate, this supportive therapy generally contributes to easing the overall symptom burden linked to testosterone deficiency, such as symptoms related to physical discomfort or systemic imbalance. This treatment may assist with maintaining functional stability in key physiological areas. One goal of this supportive relief is to help patients cope more steadily with symptom fluctuations: “The therapy supports the patient during difficult episodes by easing distress.” This includes helping with symptom clusters that interfere with daily comfort, such as diminished libido and fatigue.


Quick Fact: Relief for Symptoms that Interfere with Daily Functioning

Eligibility and Restrictions for Use

Who Can and Cannot Use Depo-Testosterone (Testosterone)?

The eligibility for using Depo-Testosterone is strictly defined by regulatory documents, limiting the population to Adult Males with documented Primary or Hypogonadotropic Hypogonadism.

Absolute Contraindications

Official labeling specifies several groups and conditions who must not use the medicine:

  • Gender: Use is contraindicated in women.
  • Reproductive Status: The medicine is contraindicated during pregnancy.
  • Cancer: Males with known or suspected carcinoma of the prostate gland or carcinoma of the breast.
  • Severe Organ Disease: Patients with serious cardiac, hepatic, or renal disease.
  • Hypersensitivity: Known allergy to the drug or any of its components.

Age- and Condition-Based Restrictions

Population Group Regulatory Status
Pediatric patients below 12 years Safety and effectiveness have not been established
Men with age-related hypogonadism Safety and efficacy have not been established
Uncontrolled Hypertension Use is not recommended

Use is restricted to treating documented deficiency; use for the enhancement of athletic performance is contraindicated.

What should I know about interactions with other medicines?

Interactions with Other Medicines and Products

The official regulatory profile for Depo-Testosterone (Testosterone cypionate) documents several key interactions primarily requiring procedural constraints and close monitoring of co-administered medicines, rather than absolute prohibitions.

Documented Interaction Patterns

Interacting Medicine Category Official Interaction Statement (Regulatory Language)
Oral Anticoagulants (e.g., Warfarin) Co-administration is documented to increase the activity of the anticoagulant, potentially necessitating a reduction in the dosage of the anticoagulant agent.
Hypoglycemic Agents (e.g., Insulin) Testosterone may decrease blood glucose levels, which is officially documented to decrease the requirements for insulin or other hypoglycemic agents in diabetic patients.
Corticosteroids (and ACTH) Co-administration may enhance the risk of edema formation (fluid retention), a caution specifically emphasized for patients with underlying cardiac, renal, or hepatic disease.
Enzyme Inducers (e.g., Barbiturates) Concurrent use is documented to potentially result in an increased metabolic clearance of testosterone.

Interaction Context Constraints

The interaction profile mandates that co-administration with oral anticoagulants or hypoglycemic agents requires supervision and dosage adjustment of the interacting medicine to maintain stable therapeutic outcomes. The interaction with corticosteroids constitutes a specific pharmacodynamic risk of additive fluid retention.

Mechanism of Action

Testosterone, released from the Depo-Testosterone ester, is a lipophilic steroid that functions as a highly specific agonist for the intracellular Androgen Receptor (AR). Free testosterone diffuses across the plasma membrane into target cells, such as those in skeletal muscle, bone, and the liver. Within the cell, testosterone binds to the cytoplasmic or nuclear AR, causing a conformational change that facilitates the dissociation of chaperones and subsequent dimerization of the ligand-receptor complex.

The activated AR dimer translocates to the nucleus where it binds to specific DNA sequences known as Androgen Response Elements (AREs) in the promoter regions of target genes. This molecular interaction modulates gene transcription, leading to the upregulation or downregulation of various protein expressions. The resulting changes in protein synthesis mediate key intracellular cascades, including those regulating protein anabolism and bone matrix deposition. These cellular effects culminate in system-level physiological modulation of secondary sexual characteristics and the regulation of the Hypothalamic-Pituitary-Gonadal (HPG) axis via negative feedback inhibition on the pituitary release of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH).

Dosage and Administration Information

Official Administration Guidelines: Depo-Testosterone

Depo-Testosterone (Testosterone Cypionate Injection) is for use only as a deep intramuscular (IM) injection; it must not be given intravenously. Injections should be administered deep into the gluteal muscle.

Dosage and Frequency

Prior to starting therapy, a diagnosis of hypogonadism must be confirmed by ensuring that serum testosterone concentrations have been measured in the morning on at least two separate days and are below the normal range.

Administration Scope Official Guidelines
Route & Site Deep Intramuscular Injection, typically in the gluteal muscle.
Dose Range (Adult Male) 50 mg to 400 mg per dose.
Frequency Administered every two to four weeks.
Dose Adjustment The dose and schedule must be individualized based on the patient's age, diagnosis, clinical response, and the appearance of adverse reactions.
Pediatric Use Safety and efficacy have not been established. Use for delayed puberty requires careful monitoring of bone maturation.

Preparation and Procedure

Parenteral drug products should be visually inspected for particulate matter and discoloration before administration, whenever the solution and container permit. If crystals have formed due to storage at lower temperatures, warming and shaking the vial should redissolve the crystals.

Missed Dose

There are no explicitly documented procedures for a missed dose in official procedural documents; the intermittent dosing schedule requires that the next dose be administered according to the individualized schedule determined by the prescriber.

Recent Clinical Evidence

Research evidence / Overview of Studies for Depo-Testosterone (Testosterone)

Evidence for Use in Primary and Hypogonadotropic Hypogonadism

The research base for testosterone replacement therapy, including injectable forms, centers on patients diagnosed with classical hypogonadism. This includes individuals with low testosterone levels due to known causes such as issues with the testes (primary hypogonadism) or problems with the pituitary gland or hypothalamus (hypogonadotropic hypogonadism).

Studies conducted during periods of increased symptom activity primarily include Randomized Controlled Trials (RCTs). These short-term RCTs typically compared testosterone therapy against an inactive treatment, such as a placebo, and were supplemented by broader Systematic Reviews and Meta-analyses. The studies monitored outcomes related to functional imbalance. Researchers examined the data related to hormone levels, reporting patterns that suggest therapy was associated with the normalization of serum total testosterone levels within the targeted range. Studies also explored outcomes related to physical discomfort, such as sexual desire (libido) and aspects of erectile function, finding studies described measured changes in these metrics over the observed short-term intervals. Furthermore, research explored physiological outcomes, including measures of lean body mass and bone mineral density (BMD), with findings describing measured patterns in these areas during the study period.


Long-Term Studies and Follow-Up Data

The majority of high-quality Randomized Controlled Trials (RCTs) exploring the utility of testosterone therapy were conducted over short- to intermediate-term follow-up durations, typically ranging from 12 weeks to 24 months. These study durations provide context but not individual predictions about the durability of any observed changes over many years. To understand long-term effects, evidence is derived from longer Observational Studies and Patient Registries. Therefore, the data related to maintaining physiological levels and specific functional outcomes are not fully established based on the short-term controlled data alone.


Evidence in Specific and Unstudied Populations and Research Gaps

For men whose low testosterone levels are attributed only to aging—often termed late-onset hypogonadism—without a clear underlying organic cause, specific research is lacking. Regulatory and scientific bodies have noted that the efficacy and safety of testosterone replacement therapy in this specific population have not been established by the existing research base. Additionally, follow-up durations were limited in the most rigorous controlled studies, meaning long-term outcomes are not well characterized. Evidence quality varies across studies, particularly for subjective, non-sexual outcomes like mood and energy, which showed mixed findings.

Frequently Asked Questions (FAQ)

Common questions about Depo-Testosterone (Testosterone) (FAQ)


Q: How long does the effect of a Depo-Testosterone injection typically last?

Depo-Testosterone is formulated as an ester dissolved in oil, which allows for slow absorption following an intramuscular injection. This design is intended to sustain appropriate hormone levels in the body, typically allowing the medicine to be administered at intervals ranging from two to four weeks.


Q: What should a patient do if they notice unusual side effects from Depo-Testosterone?

Official information advises patients to report any unusual effects to their prescriber, pharmacist, or healthcare provider. This includes specific documented effects such as nausea, vomiting, changes in skin color, swelling in the ankles, or too frequent or persistent erections of the penis. Reporting these effects is an important step in managing the overall treatment plan.


Q: Is Depo-Testosterone a controlled substance?

Yes, regulatory documents classify Depo-Testosterone (Testosterone Cypionate Injection) as a Schedule III controlled substance under the Controlled Substances Act. This classification indicates that the medicine has an accepted medical use but also carries a potential for abuse or dependence.


Q: Is Depo-Testosterone the same as other types of testosterone shots?

No, official product information indicates that testosterone cypionate should not be used interchangeably with other testosterone compounds, such as testosterone propionate. Each different form, or ester, has a unique profile for how long it is intended to act in the body, which is why they are not used interchangeably.


Q: What is the difference between Depo-Testosterone and 'T-gel'?

Depo-Testosterone is an oil-based injectable solution designed to release the hormone slowly and sustain levels over a period of weeks. In contrast, 'T-gel' refers to topical testosterone products that are applied to the skin (transdermal), which have a different method and rate of absorption.


Q: Is Depo-Testosterone known by any other brand names?

Depo-Testosterone is the brand name for the generic compound testosterone cypionate injection. This generic form may be marketed and available under different trade names or repackaged names depending on the manufacturer and region.


Q: What happens if a scheduled Depo-Testosterone injection is missed?

If a scheduled dose is missed, patient instructions consistent with regulatory guidance advise that the patient should consult their prescriber or pharmacist immediately for a new dosing schedule. Official guidance emphasizes the importance of not using a double dose to attempt to compensate for a missed injection.


Q: Can Depo-Testosterone cause mood changes?

Yes, the official regulatory profile documents potential effects on the nervous system. These documented effects include experiencing changes in libido, as well as reports of anxiety and depression.


Q: Are there any long-term health concerns associated with taking Depo-Testosterone?

The regulatory label documents specific serious adverse reactions associated with long-term use. These include the rare development of hepatocellular carcinoma (a type of liver tumor) in patients receiving long-term, high-dose therapy. Additionally, older adults are noted to have an increased risk of developing certain prostatic disorders.


Q: What kind of routine monitoring is often done while on Depo-Testosterone?

Official information mandates that patients undergo periodic laboratory monitoring during treatment. This monitoring includes checking hemoglobin and hematocrit levels to help detect an increase in red blood cell count (polycythemia). Older patients also typically require regular monitoring of the prostate-specific antigen (PSA).


Q: Is it true that Depo-Testosterone can affect sleep patterns?

Yes, official labeling lists sleep apnea as a documented adverse reaction. The frequency of this side effect is noted in the documents as not currently known from controlled studies.


Q: Does Depo-Testosterone interact with common over-the-counter pain relievers?

Official drug interaction databases generally show no known interactions between testosterone and common over-the-counter pain relievers, such as acetaminophen. However, it is important for the prescriber to be aware of all medicines being taken.


Q: What are some food or drink restrictions while using Depo-Testosterone?

While regulatory labeling does not list specific food or drink restrictions, it does contain warnings about an increased risk of fluid retention (edema). This risk is specifically emphasized for patients with underlying heart, kidney, or liver conditions, which may relate to overall fluid and sodium intake.


Q: Is Depo-Testosterone used to treat delayed puberty?

Yes, regulatory guidance indicates that this medicine is used for replacement therapy, which includes the management of delayed puberty in males over the age of 12. Use in this population requires careful monitoring of bone maturation to ensure appropriate growth.


Q: What is the scientific classification of the drug Depo-Testosterone?

Pharmacologically, Depo-Testosterone is classified as an Androgen, which is a type of sex hormone replacement. Legally, the active ingredient is classified as a Schedule III controlled substance.


Q: Why is Depo-Testosterone given as an injection and not a pill?

The injectable form is designed to allow the hormone to be released slowly, providing an extended duration of action. The oral (pill) route for testosterone can be associated with potential liver toxicity, which is a key reason this formulation is given as an injection.


Q: Does Depo-Testosterone cause body weight changes?

Yes, official regulatory documents list weight gain as a common documented effect of the medication. This effect is likely related to the role of androgens in regulating body composition.


Q: Is hair loss a possible side effect of Depo-Testosterone?

Yes, the official regulatory profile documents male pattern baldness (hair loss) as a documented side effect of the medicine.


Q: How is Depo-Testosterone different from anabolic steroids sometimes used illicitly?

Testosterone is technically a type of anabolic androgenic steroid. The key difference is that when used illicitly, it is often taken in doses that are significantly higher than the approved therapeutic dosage. The medicine is explicitly contraindicated by the FDA for the sole purpose of enhancing athletic performance.


Q: Does taking Depo-Testosterone require any lifestyle changes?

While the label does not list mandatory lifestyle changes, official warnings regarding the risk of increasing blood pressure and causing severe fluid retention (edema) in certain patients are noted. This risk is specifically emphasized for patients with underlying heart, kidney, or liver conditions, indicating the need for monitoring aspects like fluid balance and blood pressure.


Q: Is it normal to feel tired after receiving a Depo-Testosterone injection?

Fatigue is not explicitly listed as a common side effect of the injection itself. However, regulatory information notes that if a patient abruptly discontinues the drug, especially after using high doses, they may experience fatigue and depressed mood as part of a withdrawal syndrome.


Q: Are there specific requirements for the temperature or storage of Depo-Testosterone before it's used?

Yes, the medication must be stored at Controlled Room Temperature (20° to 25°C or 68° to 77°F) and must be protected from light. It is important that the medication is not refrigerated or frozen, as cold temperatures may cause the oil vehicle to congeal.


Q: Can someone who is physically active still use Depo-Testosterone safely?

Official labeling explicitly states that the medicine has not been shown to be safe or effective for the enhancement of athletic performance. Use for this purpose is contraindicated due to the risk of serious adverse health effects.


Q: What types of common blood tests are used to check testosterone levels?

A diagnosis of deficiency requires measuring serum testosterone concentrations. During therapy, monitoring includes checks of hemoglobin and hematocrit levels (to monitor for polycythemia risk) and PSA (in older patients) to track safety and response.


Q: What should be avoided when getting a Depo-Testosterone injection?

The regulatory profile specifies that the medicine must not be given intravenously (IV), as it is only for deep intramuscular use. Also, the solution must be visually inspected for any signs of particulate matter or discoloration before the dose is withdrawn.


Q: Does research show any link between Depo-Testosterone and sleep apnea?

Yes, official labeling documents sleep apnea as an adverse reaction, though its frequency is noted as not known from controlled studies.


Q: What is the evidence regarding the effect of Depo-Testosterone on bone density?

The mechanism of action for testosterone includes regulating processes such as bone matrix deposition. Clinical studies monitored this effect, and research evidence has explored outcomes related to bone mineral density (BMD).


Q: Does Depo-Testosterone interact with medications for depression or anxiety?

Official interaction databases generally show no known interactions between testosterone and many common antidepressant or anti-anxiety medicines, but individual review of all current medications by a healthcare provider is always necessary.


Q: What do official documents say about the risks of stopping Depo-Testosterone treatment suddenly?

For individuals using very high, non-approved doses, abrupt discontinuation may lead to a withdrawal syndrome characterized by depressed mood, fatigue, irritability, and decreased libido. Drug dependence has not been documented with approved therapeutic doses.


Q: Can alcohol consumption influence the effects or side effects of Depo-Testosterone?

While alcohol is not directly restricted, the regulatory profile warns that prolonged, high-dose use of androgens has been associated with severe liver complications, including hepatocellular carcinoma. This information suggests that the use of other substances that affect the liver should be discussed with a healthcare provider.


Q: Can Depo-Testosterone affect fertility?

Yes, official documents note that high dosages may cause oligospermia (a low sperm count) through a feedback inhibition mechanism on the pituitary gland. This documented effect can potentially impact male fertility.


Q: Are there special considerations for young people receiving Depo-Testosterone?

For young people receiving the medicine, official guidelines mandate the careful monitoring of bone maturation. This monitoring is performed because androgens have the potential to cause the bone growth plates to close prematurely.


Q: How do doctors generally assess if Depo-Testosterone treatment is working?

Assessment relies on both the clinical response, meaning the patient’s reports of symptom improvement, and achieving the desired serum testosterone concentration within the normal range. This is combined with ongoing monitoring of laboratory tests like hematocrit and PSA.


Q: Is it possible to develop tolerance to Depo-Testosterone over time?

Official information states that the required dose and schedule are individualized and must be adjusted based on the patient’s ongoing clinical response and any adverse reactions. This ongoing management is necessary to maintain the therapeutic effect.

How should Depo-Testosterone (Testosterone) be stored and disposed of?

Storage and Disposal of Depo-Testosterone Injection

Depo-Testosterone (testosterone cypionate) must be stored and handled according to official regulatory specifications.

Storage Requirements

The medication must be stored at Controlled Room Temperature, defined as 20° to 25°C (68° to 77°F), and it must be protected from light. Official labeling mandates that the product not be refrigerated or stored below 20°C, as the oil-based vehicle may congeal. If congealing occurs, the vial should be warmed to redissolve the material before use. The product must be kept out of the reach of children.

Disposal Instructions

Testosterone cypionate is classified as a Controlled Substance (Schedule CIII). This classification requires that disposal of unused or expired product must follow local and national guidelines for controlled pharmaceutical waste. Unused portions remaining in a single-dose vial must be discarded immediately after the dose is withdrawn.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Depo-Testosterone (Testosterone) found in:

A-Z Index: